Our mission is grounded in the safe integration of psychedelic-assisted therapy into mental health care to alleviate persistent mental health challenges. These challenges impose significant financial burdens on the healthcare system and profoundly impact individuals and their families throughout their lives.

In both Australia and on a global scale, there is a dynamic and expanding body of research in the field of psychedelic science. The potential of psychedelic therapy is particularly promising in addressing chronic conditions that affect a large segment of the population and could serve to alleviate the strain on healthcare resources.

Our extensive course not only fulfils the emerging Australian standards but also plays a proactive role in meeting the increasing training demand for authorised prescribers of psychedelic-assisted therapy. BIYOME is utilising the most up-to-date research, clinical and community practice regarding what fundamental education for PAT administrators, therapists, and facilitators involves.

Upon completing this course and meeting the necessary skill prerequisites, you will acquire the proficiency to provide Psychedelic Assisted Therapy within the parameters of current regulatory government guidelines, fulfilling the roles of a Psychedelic Prescriber (PP), Psychedelic-Assisted Therapist (PAT), or Psychedelic Facilitator (PF).